Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Stock Transactions
SEC Form 4 Filing
Jennifer B. Damico, SVP & Controller of Pfizer Inc., reports the earn-out and subsequent transactions related to stock appreciation rights and restricted stock units.
Summary
- On February 22, 2025, Jennifer B. Damico, SVP & Controller of Pfizer Inc., executed transactions involving Pfizer's common stock.
- These transactions included the earn-out of 8,741 stock appreciation rights at a price of $30.17.
- Additionally, shares were withheld to satisfy tax obligations and cover the exercise price related to the stock appreciation rights.
- Specifically, 390 shares were withheld for tax obligations at a price of $26.3, and 7,798 shares were withheld to cover the exercise price at a price of $26.08.
- On February 23, 2025, 390 shares were withheld to satisfy tax obligations upon the vesting of restricted stock units at a price of $26.3.
- Following these transactions, Damico directly owns 9,024 shares of Pfizer common stock.
Sentiment
Score: 5
Explanation: This is a neutral filing, simply reporting stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel within Pfizer.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies like Pfizer and are comparable to similar filings from companies like Johnson & Johnson (JNJ), Merck (MRK), and AbbVie (ABBV).
- The transactions reported are typical for executives receiving stock-based compensation.
- The withholding of shares for tax obligations is a common practice across the industry.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/22/2025 | Earn-out of stock appreciation rights and withholding of shares for tax obligations and exercise price. |
| 02/23/2025 | Withholding of shares to satisfy tax obligations upon vesting of restricted stock units. |
| 02/24/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.